BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32447396)

  • 1. Whole exome sequencing in unclassified autoinflammatory diseases: more monogenic diseases in the pipeline?
    Kosukcu C; Taskiran EZ; Batu ED; Sag E; Bilginer Y; Alikasifoglu M; Ozen S
    Rheumatology (Oxford); 2021 Feb; 60(2):607-616. PubMed ID: 32447396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Center Overview of Pediatric Monogenic Autoinflammatory Diseases in the Past Decade: A Summary and Beyond.
    Wang W; Yu Z; Gou L; Zhong L; Li J; Ma M; Wang C; Zhou Y; Ru Y; Sun Z; Wei Q; Dong Y; Song H
    Front Immunol; 2020; 11():565099. PubMed ID: 33042144
    [No Abstract]   [Full Text] [Related]  

  • 3. The phenotype and genotype of Chinese adult patients with NLRP3-associated autoinflammatory disease.
    Wu N; Wu D; Miao J; Zhao M; Wang Y; Yu W; Shen M
    Clin Rheumatol; 2023 Oct; 42(10):2841-2848. PubMed ID: 37368056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study.
    Karacan İ; Balamir A; Uğurlu S; Aydın AK; Everest E; Zor S; Önen MÖ; Daşdemir S; Özkaya O; Sözeri B; Tufan A; Yıldırım DG; Yüksel S; Ayaz NA; Ömeroğlu RE; Öztürk K; Çakan M; Söylemezoğlu O; Şahin S; Barut K; Adroviç A; Seyahi E; Özdoğan H; Kasapçopur Ö; Turanlı ET
    Rheumatol Int; 2019 May; 39(5):911-919. PubMed ID: 30783801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
    Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
    J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders.
    Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY
    Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous MEFV Gene Variant and Pyrin-Associated Autoinflammation With Neutrophilic Dermatosis: A Family With a Novel Autosomal Recessive Mode of Inheritance.
    Vahidnezhad H; Youssefian L; Saeidian AH; Ziaee V; Mahmoudi H; Parvaneh N; Ashjaei B; Shahrokh S; Kamyab Hesari K; Soltani Zangbar M; Yousefi M; Zeinali S; Uitto J
    JAMA Dermatol; 2021 Dec; 157(12):1466-1471. PubMed ID: 34643647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilizing Whole-Exome Sequencing to Characterize the Phenotypic Variability of Sickle Cell Disease.
    Alsultan A; Al-Suliman AM; Aleem A; AlGahtani FH; Alfadhel M
    Genet Test Mol Biomarkers; 2018 Sep; 22(9):561-567. PubMed ID: 30183354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a novel heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMF.
    Karacan İ; Uğurlu S; Tolun A; Tahir Turanlı E; Ozdogan H
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):75-81. PubMed ID: 29148404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease.
    Stoffels M; Szperl A; Simon A; Netea MG; Plantinga TS; van Deuren M; Kamphuis S; Lachmann HJ; Cuppen E; Kloosterman WP; Frenkel J; van Diemen CC; Wijmenga C; van Gijn M; van der Meer JW
    Ann Rheum Dis; 2014 Feb; 73(2):455-61. PubMed ID: 23505238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A NOVEL MUTATION K447M (P.LYS447MET, C.1340 A>T) IDENTIFIED IN EXON 4 OF THE MEFV GENE.
    Eroz R; Dogan M; Kocabay K
    Genet Couns; 2016; 27(4):525-528. PubMed ID: 30226974
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic diagnosis of autoinflammatory disease patients using clinical exome sequencing.
    Batlle-Masó L; Mensa-Vilaró A; Solís-Moruno M; Marquès-Bonet T; Arostegui JI; Casals F
    Eur J Med Genet; 2020 May; 63(5):103920. PubMed ID: 32222431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiered analysis of whole-exome sequencing for epilepsy diagnosis.
    Dunn PJ; Maher BH; Albury CL; Stuart S; Sutherland HG; Maksemous N; Benton MC; Smith RA; Haupt LM; Griffiths LR
    Mol Genet Genomics; 2020 May; 295(3):751-763. PubMed ID: 32146541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexity in unclassified auto-inflammatory disease: a case report illustrating the potential for disease arising from the allelic burden of multiple variants.
    Tucker LB; Lamot L; Niemietz I; Chung BK; Cabral DA; Houghton K; Petty RE; Morishita KA; Rice GI; Turvey SE; Gibson WT; Brown KL
    Pediatr Rheumatol Online J; 2019 Oct; 17(1):70. PubMed ID: 31660995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic panel screening in patients with clinically unclassified systemic autoinflammatory diseases.
    Demir F; Doğan ÖA; Demirkol YK; Tekkuş KE; Canbek S; Karadağ ŞG; Sönmez HE; Ayaz NA; Doğanay HL; Sözeri B
    Clin Rheumatol; 2020 Dec; 39(12):3733-3745. PubMed ID: 32458238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders.
    Guzel F; Romano M; Keles E; Piskin D; Ozen S; Poyrazoglu H; Kasapcopur O; Demirkaya E
    Front Immunol; 2021; 12():666273. PubMed ID: 34177904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro analysis of the functional effects of an NLRP3 G809S variant with the co-existence of MEFV haplotype variants in atypical autoinflammatory syndrome.
    Kubota K; Ohnishi H; Teramoto T; Matsui E; Murase K; Kanoh H; Kato Z; Kaneko H; Seishima M; Kondo N
    J Clin Immunol; 2013 Feb; 33(2):325-34. PubMed ID: 23015306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations.
    Martín-Nalda A; Fortuny C; Rey L; Bunney TD; Alsina L; Esteve-Solé A; Bull D; Anton MC; Basagaña M; Casals F; Deyá A; García-Prat M; Gimeno R; Juan M; Martinez-Banaclocha H; Martinez-Garcia JJ; Mensa-Vilaró A; Rabionet R; Martin-Begue N; Rudilla F; Yagüe J; Estivill X; García-Patos V; Pujol RM; Soler-Palacín P; Katan M; Pelegrín P; Colobran R; Vicente A; Arostegui JI
    J Clin Immunol; 2020 Oct; 40(7):987-1000. PubMed ID: 32671674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases.
    Pena LDM; Jiang YH; Schoch K; Spillmann RC; Walley N; Stong N; Rapisardo Horn S; Sullivan JA; McConkie-Rosell A; Kansagra S; Smith EC; El-Dairi M; Bellet J; Keels MA; Jasien J; Kranz PG; Noel R; Nagaraj SK; Lark RK; Wechsler DSG; Del Gaudio D; Leung ML; Hendon LG; Parker CC; Jones KL; ; Goldstein DB; Shashi V
    Genet Med; 2018 Apr; 20(4):464-469. PubMed ID: 28914269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of combined
    Nomani H; Deng Z; Navetta-Modrov B; Yang J; Yun M; Aroniadis O; Gorevic P; Aksentijevich I; Yao Q
    Front Immunol; 2023; 14():1265404. PubMed ID: 37928541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.